2021Bone Mineral DensityStudiesLow bone mass in people living with HIV on long-term anti-retroviral therapy: A single center study in UgandaREAD MORE
Bone Mineral DensityStudiesBone Mineral Density in Antiretroviral Therapy-Naïve HIV-1–Infected Young Adult -Women Using Depot Medroxyprogesterone Acetate or Nonhormonal Contraceptives in UgandaREAD MORE
2022Bone Mineral DensityStudiesIntramuscular depot medroxyprogesterone acetate accentuates bone loss associated with tenofovir disoproxil fumarate-containing antiretroviral therapy initiation in young women living with HIV (the BONE: CARE study): a prospective cohort study in UgandaREAD MORE
2021Bone Mineral DensityStudiesBone Mineral Density in Antiretroviral Therapy‐Naïve HIV‐1–Infected Young Adult ‐Women Using Depot Medroxyprogesterone Acetate or Nonhormonal Contraceptives in UgandaREAD MORE
